AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Volgrim-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Volentis Healthcare Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Volgrim-M1 Tablet SR

Diabetace-Duo SR tablets are classified as antidiabetic medications, a dual-drug formulation for adult type 2 diabetes management. This medication helps regulate blood glucose. Diabetace-Duo SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar; premature discontinuation, without medical counsel, risks elevated blood glucose, potentially leading to kidney complications, vision loss, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly influences diabetes control. Hypoglycemia (low blood sugar) is a common side effect; recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them. Maintain regular meals and carry a readily available fast-acting glucose source (e.g., sugary foods, fruit juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring, along with blood tests to track blood cell counts and liver function, may be recommended.

Uses of Volgrim-M1 Tablet SR

Managing type 2 diabetes

Major Benefits of Volgrim-M1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Volgrim-M1 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Volgrim-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Volgrim-M1 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Volgrim-M1 Tablet SR should be administered with a meal.

How Volgrim-M1 Tablet SR works:

Volgrim-M1 SR tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Volgrim-M1 SR tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Volgrim-M1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Use of Volgrim-M1 SR tablets is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates the medication may harm the nursing infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Volgrim-M1 SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Volgrim-M1 SR tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Volgrim-M1 SR tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver dysfunction, Volgrim-M1 SR tablets should typically commence at a reduced dosage; however, their use is contraindicated in cases of severe liver disease.

What if you forget to take Volgrim-M1 Tablet SR :

Should you forget a Volgrim-M1 Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Volgrim-M1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Volgrim-M1 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Volgrim-M1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Volgrim-M1 Tablet SR and seek immediate medical attention.
Volgrim-M1 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride boosts insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Volgrim-M1 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Volgrim-M1 Tablet SR can lead to Vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, supplemental Vitamin B12 is recommended at least annually by some researchers.
Volgrim-M1 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Volgrim-M1 Tablet SR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Volgrim-M1 Tablet SR
84
MRP 98
13% off